Is Exact Sciences Corporation (EXAS) a Buy, Sell, or Hold?
Exact Sciences Corporation
NASDAQ:EXAS
$104.91 USD
$0 (0.0%)
- Volume
- 21.56M
- Average Volume
- 2.53M
- Market Capitalization
- $20.03B
- P/E Ratio
- -95.69
- Dividend Yield
- 0.00%
- Price Target
- $105.00
- Year High
- $104.98
- Year Low
- $38.81
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $2.23
NUMBER OF INSIDERS BUYING (LAST 12 MONTHS)
67
NUMBER OF INSIDERS SELLING (LAST 12 MONTHS)
113
AMOUNT OF INSIDER SELLING (LAST 12 MONTHS)
$ 2.16M
EXAS Estimated and Actual Revenue by Quarter
Get MSFT Insider Trade Alerts
EXAS Insider Trading History
| Insider Name | Title | Date | Transaction | Cost | Filing Date |
|---|---|---|---|---|---|
| Baranick Brian | officer: EVP, GM, Precision Oncology | 2026-03-23 | A-Award | 0 | 2026-03-23 |
| Baranick Brian | officer: EVP, GM, Precision Oncology | 2026-03-23 | D-Return | 0 | 2026-03-23 |
| Baranick Brian | officer: EVP, GM, Precision Oncology | 2026-03-23 | D-Return | 0 | 2026-03-23 |
| Herriott James | officer: SVP, General Counsel & Sec | 2026-03-23 | D-Return | 0.01 | 2026-03-23 |
| Herriott James | officer: SVP, General Counsel & Sec | 2026-03-23 | D-Return | 92.62 | 2026-03-23 |
| Herriott James | officer: SVP, General Counsel & Sec | 2026-03-23 | D-Return | 98.18 | 2026-03-23 |
| Herriott James | officer: SVP, General Counsel & Sec | 2026-03-23 | D-Return | 0 | 2026-03-23 |
| Bloomer Aaron | officer: EVP, Chief Financial Officer | 2026-03-23 | A-Award | 0 | 2026-03-23 |
| Bloomer Aaron | officer: EVP, Chief Financial Officer | 2026-03-23 | D-Return | 0 | 2026-03-23 |
| Bloomer Aaron | officer: EVP, Chief Financial Officer | 2026-03-23 | D-Return | 0 | 2026-03-23 |
| Condella Sarah | officer: EVP, Human Resources | 2026-03-23 | A-Award | 0 | 2026-03-23 |
| Condella Sarah | officer: EVP, Human Resources | 2026-03-23 | D-Return | 0 | 2026-03-23 |
| Condella Sarah | officer: EVP, Human Resources | 2026-03-23 | D-Return | 21.68 | 2026-03-23 |
| Condella Sarah | officer: EVP, Human Resources | 2026-03-23 | D-Return | 44.37 | 2026-03-23 |
| Condella Sarah | officer: EVP, Human Resources | 2026-03-23 | D-Return | 92.62 | 2026-03-23 |
| Condella Sarah | officer: EVP, Human Resources | 2026-03-23 | D-Return | 98.18 | 2026-03-23 |
| Condella Sarah | officer: EVP, Human Resources | 2026-03-23 | D-Return | 0 | 2026-03-23 |
| Conroy Kevin T | director, officer: President and CEO | 2026-03-23 | A-Award | 0 | 2026-03-23 |
| Conroy Kevin T | director, officer: President and CEO | 2026-03-23 | D-Return | 0 | 2026-03-23 |
| Conroy Kevin T | director, officer: President and CEO | 2026-03-23 | D-Return | 21.68 | 2026-03-23 |
| Conroy Kevin T | director, officer: President and CEO | 2026-03-23 | D-Return | 44.37 | 2026-03-23 |
| Conroy Kevin T | director, officer: President and CEO | 2026-03-23 | D-Return | 92.62 | 2026-03-23 |
| Conroy Kevin T | director, officer: President and CEO | 2026-03-23 | D-Return | 98.18 | 2026-03-23 |
| Conroy Kevin T | director, officer: President and CEO | 2026-03-23 | D-Return | 0 | 2026-03-23 |
| ORVILLE JACOB A | officer: EVP, GM, Screening | 2026-03-23 | A-Award | 0 | 2026-03-23 |
| ORVILLE JACOB A | officer: EVP, GM, Screening | 2026-03-23 | D-Return | 0 | 2026-03-23 |
| ORVILLE JACOB A | officer: EVP, GM, Screening | 2026-03-23 | D-Return | 98.18 | 2026-03-23 |
| ORVILLE JACOB A | officer: EVP, GM, Screening | 2026-03-23 | D-Return | 0 | 2026-03-23 |
| COWARD D SCOTT | director | 2026-03-23 | D-Return | 0.01 | 2026-03-23 |
| COWARD D SCOTT | director | 2026-03-23 | D-Return | 0 | 2026-03-23 |
| COWARD D SCOTT | director | 2026-03-23 | D-Return | 0.01 | 2026-03-23 |
| COWARD D SCOTT | director | 2026-03-23 | D-Return | 44.37 | 2026-03-23 |
| COWARD D SCOTT | director | 2026-03-23 | D-Return | 92.62 | 2026-03-23 |
| COWARD D SCOTT | director | 2026-03-23 | D-Return | 98.18 | 2026-03-23 |
| Petrovic Shacey | director | 2026-03-23 | D-Return | 0.01 | 2026-03-23 |
| Petrovic Shacey | director | 2026-03-23 | D-Return | 0 | 2026-03-23 |
| Petrovic Shacey | director | 2026-03-23 | D-Return | 0.01 | 2026-03-23 |
| Zanotti Katherine S | director | 2026-03-23 | D-Return | 0.01 | 2026-03-23 |
| Zanotti Katherine S | director | 2026-03-23 | D-Return | 0 | 2026-03-23 |
| Popovits Kimberly J | director | 2026-03-23 | D-Return | 0.01 | 2026-03-23 |
| Popovits Kimberly J | director | 2026-03-23 | D-Return | 0 | 2026-03-23 |
| Doyle James Edward | director | 2026-03-23 | D-Return | 0.01 | 2026-03-23 |
| Doyle James Edward | director | 2026-03-23 | D-Return | 0 | 2026-03-23 |
| Clancy Paul J | director | 2026-03-23 | D-Return | 0.01 | 2026-03-23 |
| Clancy Paul J | director | 2026-03-23 | D-Return | 0 | 2026-03-23 |
| Barber Michael J | director | 2026-03-23 | D-Return | 0.01 | 2026-03-23 |
| Barber Michael J | director | 2026-03-23 | D-Return | 0 | 2026-03-23 |
| Barber Michael J | director | 2026-03-23 | D-Return | 0 | 2026-03-23 |
| Trigg Leslie | director | 2026-03-23 | D-Return | 0.01 | 2026-03-23 |
| Trigg Leslie | director | 2026-03-23 | D-Return | 0 | 2026-03-23 |
| Conroy Kevin T | director, officer: President and CEO | 2026-02-27 | M-Exempt | 0 | 2026-03-03 |
| Conroy Kevin T | director, officer: President and CEO | 2026-02-27 | F-InKind | 103.25 | 2026-03-03 |
| Conroy Kevin T | director, officer: President and CEO | 2026-02-27 | M-Exempt | 0 | 2026-03-03 |
| Conroy Kevin T | director, officer: President and CEO | 2026-02-27 | F-InKind | 103.25 | 2026-03-03 |
| Conroy Kevin T | director, officer: President and CEO | 2026-02-27 | M-Exempt | 0 | 2026-03-03 |
| Conroy Kevin T | director, officer: President and CEO | 2026-02-27 | F-InKind | 103.25 | 2026-03-03 |
| Conroy Kevin T | director, officer: President and CEO | 2026-02-27 | M-Exempt | 0 | 2026-03-03 |
| Conroy Kevin T | director, officer: President and CEO | 2026-02-27 | M-Exempt | 0 | 2026-03-03 |
| Conroy Kevin T | director, officer: President and CEO | 2026-02-27 | M-Exempt | 0 | 2026-03-03 |
| Condella Sarah | officer: EVP, Human Resources | 2026-02-27 | M-Exempt | 5.03 | 2026-03-03 |
| Condella Sarah | officer: EVP, Human Resources | 2026-02-27 | F-InKind | 103.38 | 2026-03-03 |
| Condella Sarah | officer: EVP, Human Resources | 2026-02-27 | M-Exempt | 5.03 | 2026-03-03 |
| Condella Sarah | officer: EVP, Human Resources | 2026-02-25 | A-Award | 0 | 2026-02-27 |
| Herriott James | officer: SVP, General Counsel & Sec | 2026-02-25 | A-Award | 0 | 2026-02-27 |
| Conroy Kevin T | director, officer: President and CEO | 2026-02-25 | A-Award | 0 | 2026-02-27 |
| Conroy Kevin T | director, officer: President and CEO | 2026-02-25 | F-InKind | 103.45 | 2026-02-27 |
| Conroy Kevin T | director, officer: President and CEO | 2026-02-25 | A-Award | 0 | 2026-02-27 |
| Baranick Brian | officer: EVP, GM, Precision Oncology | 2026-02-25 | A-Award | 0 | 2026-02-27 |
| ORVILLE JACOB A | officer: EVP, GM, Screening | 2026-02-25 | A-Award | 0 | 2026-02-27 |
| Bloomer Aaron | officer: EVP, Chief Financial Officer | 2026-02-25 | A-Award | 0 | 2026-02-27 |
| ORVILLE JACOB A | officer: EVP, GM, Screening | 2025-12-23 | A-Award | 0 | 2025-12-30 |
| ORVILLE JACOB A | officer: EVP, GM, Screening | 2025-12-23 | A-Award | 0 | 2025-12-30 |
| ORVILLE JACOB A | officer: EVP, GM, Screening | 2025-12-23 | A-Award | 0 | 2025-12-30 |
| ORVILLE JACOB A | officer: EVP, GM, Screening | 2025-12-23 | F-InKind | 101.82 | 2025-12-30 |
| ORVILLE JACOB A | officer: EVP, GM, Screening | 2025-12-23 | F-InKind | 101.82 | 2025-12-30 |
| ORVILLE JACOB A | officer: EVP, GM, Screening | 2025-12-23 | F-InKind | 101.82 | 2025-12-30 |
| ORVILLE JACOB A | officer: EVP, GM, Screening | 2025-12-23 | M-Exempt | 0 | 2025-12-30 |
| ORVILLE JACOB A | officer: EVP, GM, Screening | 2025-12-23 | M-Exempt | 0 | 2025-12-30 |
| ORVILLE JACOB A | officer: EVP, GM, Screening | 2025-12-23 | F-InKind | 101.82 | 2025-12-30 |
| ORVILLE JACOB A | officer: EVP, GM, Screening | 2025-12-23 | F-InKind | 101.82 | 2025-12-30 |
| ORVILLE JACOB A | officer: EVP, GM, Screening | 2025-12-23 | M-Exempt | 0 | 2025-12-30 |
| ORVILLE JACOB A | officer: EVP, GM, Screening | 2025-12-23 | F-InKind | 101.82 | 2025-12-30 |
| ORVILLE JACOB A | officer: EVP, GM, Screening | 2025-12-23 | M-Exempt | 0 | 2025-12-30 |
| ORVILLE JACOB A | officer: EVP, GM, Screening | 2025-12-23 | F-InKind | 101.82 | 2025-12-30 |
| ORVILLE JACOB A | officer: EVP, GM, Screening | 2025-12-23 | M-Exempt | 0 | 2025-12-30 |
| ORVILLE JACOB A | officer: EVP, GM, Screening | 2025-12-23 | F-InKind | 101.82 | 2025-12-30 |
| ORVILLE JACOB A | officer: EVP, GM, Screening | 2025-12-23 | M-Exempt | 0 | 2025-12-30 |
| Baranick Brian | officer: EVP, GM, Precision Oncology | 2025-12-24 | A-Award | 0 | 2025-12-30 |
| Baranick Brian | officer: EVP, GM, Precision Oncology | 2025-12-24 | F-InKind | 101.59 | 2025-12-30 |
| Baranick Brian | officer: EVP, GM, Precision Oncology | 2025-12-23 | A-Award | 0 | 2025-12-30 |
| Baranick Brian | officer: EVP, GM, Precision Oncology | 2025-12-23 | A-Award | 0 | 2025-12-30 |
| Baranick Brian | officer: EVP, GM, Precision Oncology | 2025-12-23 | F-InKind | 101.82 | 2025-12-30 |
| Baranick Brian | officer: EVP, GM, Precision Oncology | 2025-12-23 | F-InKind | 101.82 | 2025-12-30 |
| Baranick Brian | officer: EVP, GM, Precision Oncology | 2025-12-23 | M-Exempt | 0 | 2025-12-30 |
| Baranick Brian | officer: EVP, GM, Precision Oncology | 2025-12-23 | M-Exempt | 0 | 2025-12-30 |
| Baranick Brian | officer: EVP, GM, Precision Oncology | 2025-12-23 | F-InKind | 101.82 | 2025-12-30 |
| Baranick Brian | officer: EVP, GM, Precision Oncology | 2025-12-23 | F-InKind | 101.82 | 2025-12-30 |
| Baranick Brian | officer: EVP, GM, Precision Oncology | 2025-12-23 | M-Exempt | 0 | 2025-12-30 |
| Baranick Brian | officer: EVP, GM, Precision Oncology | 2025-12-23 | F-InKind | 101.82 | 2025-12-30 |
| Baranick Brian | officer: EVP, GM, Precision Oncology | 2025-12-23 | M-Exempt | 0 | 2025-12-30 |